• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP Back to Search Results
Catalog Number VBC081002
Device Problems Break (1069); Failure to Deliver (2338)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/15/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).Lot/serial: (b)(4) = udi: (b)(4).The review of the manufacturing records verified that the lots met all pre-release specifications.
 
Event Description
It was reported to gore that a 8mm x 10cm gore® viabahn® endoprothesis was to be implanted for av revision in the left forearm.The viabahn® device was advanced over a 0.035 terumo stiff guide wire through a 10fr terumo sheath to the target lesion and initiated deployment.However it was stated the viabahn® device was not fully expanded after the deployment line was pulled out from the catheter.The deployment line seemed broken.A cut-down from the brachial artery below elbow was performed to remove the partially expanded viabahn® device together with the sheath out of the patient.Then a new viabahn® device was used to continue the procedure successfully without any reported issue to the patient.
 
Manufacturer Narrative
The device was returned for analysis.The engineering evaluation result stated that no knob nor connected deployment line was returned.At approximately 3 cm from hub, there was columnar failure of dual lumen.There was 1 cm of dual lumen stretched out near the transition.Approximately 5 cm of distal shaft, upon which the endoprosthesis is mounted, was exposed at transition.The endoprosthesis was longitudinally compressed and displaced on shaft towards the tip.The outer braided constraining line was completely deployed with approximately 1 cm of the inner braided constraining line deployed.The endoprosthesis was partially expanded with approximately 5.7 cm of endoprosthesis still constrained.The deployment line connected to the endoprosthesis went into the transition port.There was a broken fiber in the deployment line approximately 12 cm from endoprosthesis.Deployment was able to be continued with traction of the deployment line at the endoprosthesis.Based on the device examination performed, no manufacturing anomalies were identified.Per the gore® viabahn® endoprosthesis instructions for use (ifu), it is stated that complications and adverse events that can occur when using any endovascular device.These complications include but are not limited to deployment failure.A warning is given as ¿inadvertent, partial, or failed deployment of the endoprosthesis may require surgical intervention.¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key7590332
MDR Text Key110713415
Report Number2017233-2018-00325
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor
Type of Report Initial,Followup
Report Date 06/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/12/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/29/2020
Device Catalogue NumberVBC081002
Device Lot Number17442001
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/23/2018
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age37 YR
-
-